PCAR vs SPRO · P/E 25, rev $33.66B vs P/E 9.6, rev $258.0K
PACCAR Inc (PCAR) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
PCAR currently screens at market cap $61.75B and trailing P/E 25.0. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the PCAR and SPRO stock pages for the full models.
Not investment advice.